Sotera Health Q1 2023 revenue falls 7% to $221M; net income drops to $3M; reaffirms 2023 outlook

Sotera Health Co

2023-Q1 EPS reported $0.01 revenue$220,590,000

Net revenues $221M, down 6.8% YoY; constant currency down 5.3%, driven by Nordion Cobalt-60 harvest timing.
Net income $3M ($0.01 diluted EPS) vs $31M ($0.11) in Q1 2022; Adjusted EPS $0.13 vs $0.22.
Adjusted EBITDA $98M, down 14.6% from $115M; total debt $2.3B, net leverage 3.4x.
Company reaffirms 2023 outlook despite Q1 declines attributed to expected Nordion harvest schedule timing.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Sotera Health Co reported the quarter ended March 31, 2023 results: revenue $221 million, net income $3 million, EPS $0.01 per diluted share. Guidance reaffirmed.

Period: the quarter ended March 31, 2023
Revenue: $221 million
Net income: $3 million
EPS: $0.01 per diluted share
Guidance: reaffirmed
Result: reported results

Exact text from the filing

First-quarter 2023 net revenues decreased 6.8% to $221 million, compared with $237 million in the first-quarter 2022. Net revenues decreased 5.3% on a constant currency basis. Net income (“net income”) was $3 million, or $0.01 per diluted share, compared with net income of $31 million, or $0.11 per diluted share in the first-quarter 2022.

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

Sotera Health Co filing history →

Source: SEC EDGAR

accession 0001822479-23-000030

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.